Loading…
Sectoral / Thematic · UTI Mutual Fund · AMFI code 100806UTI - Healthcare Fund
Disclosed for 95 months, Jul 2017 to Sep 2026.
Portfolio value
₹403 Cr
up ₹18.1 Cr vs May 2018
- Stocks held
- 27
- unchanged
- Top 10 weight
- 67.1%
- of the portfolio in its ten largest
- Cash & debt
- 3.4%
- cash, money market and debt
- Moves this month
- 2 in · 2 out
- added to 10, trimmed 9
UTI - Healthcare Fund is an active equity fund in the Sectoral / Thematic category from UTI Mutual Fund. In June 2018 it disclosed 27 stocks worth ₹403 Cr, up ₹18.1 Cr from May 2018. Its largest positions were Sun Pharmaceutical Industries Limited (10.2%), Cipla Limited (9.6%), Alkem Laboratories Limited (7.8%); the ten largest together made up 67.1% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 84.3% of its equity. Cash and debt stood at 3.4%. Compared with May 2018 the fund entered 2 new stocks and exited 2.
Against 229 other Sectoral / Thematic funds
Concentration
92%
Top-10 weight is higher than 92% of peers
Breadth
11%
Holds more stocks than 11% of peers
Cash
51%
Holds more cash than 51% of peers
What these mean: concentration · cash
Holdings in June 2018
Download CSVEvery line the fund disclosed, with the change against May 2018. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 10.20% | up 1.11 pts | ₹41.1 Cr | up ₹6.1 Cr | Added |
| Cipla Limited | 9.63% | up 1.05 pts | ₹38.8 Cr | up ₹5.8 Cr | Added |
| Alkem Laboratories Limited | 7.81% | down 0.48 pts | ₹31.4 Cr | down ₹43 L | Trimmed |
| Pfizer Limited | 7.44% | down 0.08 pts | ₹30 Cr | up ₹1 Cr | Added |
| Torrent Pharmaceuticals Limited | 7.41% | down 0.41 pts | ₹29.8 Cr | down ₹22 L | Trimmed |
| IPCA Laboratories Limited | 6.02% | down 0.02 pts | ₹24.2 Cr | up ₹1 Cr | Added |
| Sanofi India Limited | 5.48% | up 0.22 pts | ₹22.1 Cr | up ₹1.9 Cr | Added |
| Aurobindo Pharma Limited | 4.72% | up 0.19 pts | ₹19 Cr | up ₹1.6 Cr | Added |
| Divi's Laboratories Limited | 4.54% | up 0.40 pts | ₹18.3 Cr | up ₹2.4 Cr | Added |
| Ajanta Pharma Limited | 3.87% | down 0.10 pts | ₹15.6 Cr | up ₹32 L | Added |
| Lupin Limited | 3.61% | up 1.41 pts | ₹14.6 Cr | up ₹6.1 Cr | Added |
| Dr. Reddy's Laboratories Limited | 3.46% | up 1.34 pts | ₹13.9 Cr | up ₹5.8 Cr | Added |
| Cash, TREPS & receivables | 3.39% | down 0.34 pts | ₹13.6 Cr | down ₹69 L | Trimmed |
| FDC Limited | 2.89% | down 0.08 pts | ₹11.6 Cr | up ₹22 L | Added |
| Dishman Carbogen Amcis Limited | 2.86% | down 0.92 pts | ₹11.5 Cr | down ₹3 Cr | Trimmed |
| Zydus Lifesciences Limited | 2.68% | down 0.01 pts | ₹10.8 Cr | up ₹46 L | Added |
| Max India Limited | 2.24% | down 0.48 pts | ₹9 Cr | down ₹1.4 Cr | Trimmed |
| Thyrocare Technologies Limited | 2.09% | down 0.24 pts | ₹8.4 Cr | down ₹53 L | Trimmed |
| Narayana Hrudayalaya Limited | 1.93% | down 0.08 pts | ₹7.8 Cr | up ₹3 L | Held |
| Dr. Lal Path Labs Limited | 1.88% | up 0.11 pts | ₹7.6 Cr | up ₹76 L | Added |
| Strides Pharma Science Limited | 1.62% | down 0.11 pts | ₹6.5 Cr | down ₹12 L | Trimmed |
| Indoco Remedies Limited | 1.46% | down 0.20 pts | ₹5.9 Cr | down ₹51 L | Trimmed |
| Sun Pharma Advanced Research Company Limited | 1.21% | down 0.18 pts | ₹4.9 Cr | down ₹48 L | Trimmed |
| Apollo Hospitals Enterprise Limited | 0.50% | up 0.03 pts | ₹2 Cr | up ₹19 L | Added |
| Syngene International Limited | 0.41% | up 0.41 pts | ₹1.6 Cr | up ₹1.6 Cr | New |
| Shilpa Medicare Limited | 0.27% | down 0.01 pts | ₹1.1 Cr | up ₹0 L | Held |
| Solara Active Pharma Sciences Limited | 0.25% | up 0.25 pts | ₹1 Cr | up ₹1 Cr | New |
| Unichem Laboratories Limited | 0.13% | down 0.02 pts | ₹51 L | down ₹4 L | Trimmed |
What changed, May 2018 to Jun 2018
New New positions (2)
- Syngene International Limited0.4% · ₹1.6 Cr
- Solara Active Pharma Sciences Limited0.2% · ₹1 Cr
Exited Exited (2)
- Natco Pharma Limitedwas 2.6% · ₹10.1 Cr
- EQ SOLARA ACTIVE PHARMA SCIENCES LTDwas 0.1% · ₹56 L
Added Biggest additions
- Sun Pharmaceutical Industries Limitedup ₹6.1 Cr (+1.11% pts)
- Lupin Limitedup ₹6.1 Cr (+1.41% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since May 2018, the weight rose most in Pharmaceuticals & Biotechnology (+1.6 pts), and fell most in Pharmaceuticals (−1.3 pts) and Healthcare Services (−0.3 pts).
- Pharmaceuticals & Biotechnology82.7% → 84.3%+1.6 pts
- Pharmaceuticals7.6% → 6.3%−1.3 pts
- Healthcare Services9.7% → 9.4%−0.3 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Oct 2017 | Mar 2018 | May 2018 | Jun 2018 |
|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 71.7% | 76.5% | 82.7% | 84.3% |
| Healthcare Services | 9.5% | 9.5% | 9.7% | 9.4% |
| Pharmaceuticals | 14.8% | 10.6% | 7.6% | 6.3% |
Allocation in Jun 2018change vs May 2018
- Pharmaceuticals & Biotechnology (17)84.3%▲ 1.6 pts
- Healthcare Services (6)9.4%▼ 0.3 pts
- Pharmaceuticals (4)6.3%▼ 1.3 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Jun 2018
3.4%
▼ 0.3 pts vs May 2018
- Cash alone
- 3.4%
- cash and net receivables
- A year earlier
- —
- no disclosure
- Last 12 months
- 1.5% – 7.3%
- lowest to highest · record 7.3% in Jul 2017
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.